Article
Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients
- Author:
- Severs GA
- Lawlor TH
- Purcell SM
- Adler DJ
- Thompson R
Infliximab is a chimeric immunoglobulin G1κ monoclonal antibody against tumor necrosis factor α (TNF-α), a proinflammatory cytokine that...